A novel vascular endothelial growth factor-trap KP-VR2 with enhanced ligand blocking
M.-R. Kim, B. Kim, Y. Na, J. Yoo, S.-H. Kim, I.-R. Seo
This study develops KP-VR2, a novel VEGF-Trap that neutralizes VEGF-A, VEGF-B, and PlGF, showing improved antitumor efficacy compared to existing therapies.
bioRxiv · Feb 2, 2021 · PreprintCancer Biology